Physician profile
Claire H Handler
NPI 1023456480
$1,123.02
in general payments reported to CMS, 2019-2025
18 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $387 · 2022: $255 · 2023: $181 · 2024: $154 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $255.31 | 2021-2024 | Velphoro, Korsuva |
| Ani Pharmaceuticals, INC. | $132.82 | 2023-2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $108.32 | 2021-2025 | |
| Aurinia Pharma U.S., INC. | $76.39 | 2021-2024 | Lupkynis |
| Vifor Pharma, INC. | $72.29 | 2021-2025 | Veltassa |
| Astrazeneca Pharmaceuticals Lp | $72.28 | 2021-2024 | Farxiga |
| Daiichi Sankyo INC. | $69.19 | 2021-2022 | |
| Opko Pharmaceuticals, LLC | $56.56 | 2021-2023 | Rayaldee |
| Vantive US Healthcare LLC | $56.53 | 2025 | Renal - Pd |
| Amgen INC. | $55.53 | 2021-2022 | |
| Novo Nordisk INC | $33.46 | 2021 | |
| Calliditas Therapeutics US INC. | $33.33 | 2023-2025 | Tarpeyo |
| Ultragenyx Pharmaceutical INC. | $29.29 | 2021 | |
| Glaxosmithkline, LLC. | $16.89 | 2023 | Benlysta |
| Mallinckrodt Hospital Products INC. | $15.22 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.77 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.76 | 2023 | Ultomiris |
| Akebia Therapeutics INC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.